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ABSTRACT
Orexins are neuropeptides released from neurons that are primarily localized 
in the hypothalamus but which project to several brain regions including to the 
basal forebrain, a region known to be crucial for normal attentional 
performance in rats. Our previous research demonstrated that orexin receptor 
blockade impairs attention, while infusions of orexin A into the lateral ventricle 
enhance attentional performance. The goal of the present experiments was to 
test whether the the attention-enhancing effects of orexin A could be 
reproduced by infusions directly into the basal forebrain and whether the basal 
forebrain cholinergic inputs to the medial prefrontal cortex are crucial to the 
performance-enhancing effects of orexin A. Male FBNF1 hybrid rats were 
trained in a sustained attention task that required discrimination of visual 
signals (500,100 or 25-ms illumination of a central panel light) from trials when 
no signal was presented. In experiment 1, after stable performance levels 
were established, rats received guide cannulae implanted bilaterally into the 
basal forebrain. In experiment 2, rats received both intraventricular guide 
cannula implantation and infusions of either the immunotoxin 192-lgG-saporin 
or vehicle into the medial prefrontal cortex. Postsurgically, rats were trained in 
a version of the task which increased attentional demands by presenting a 
visual distracter during the middle block of trials within a testing session. In 
experiment 1, rats then received 0 (vehicle), 0.1, 1.0 or 10.0pM orexin A in a 
counterbalanced order prior to task performance. Following vehicle 
administration, attentional performance decreased from block 1 to block 2, 
when the distracter was presented. This distracter-induced impairment in 
accuracy was attenuated following administration of the highest orexin A dose. 
In experiment 2, rats received infusions of 0 (vehicle), 10, 100 or 1000pM 
orexin A in a counterbalanced order prior to task performance. Compared with 
sham-lesioned animals, animals with a loss of cholinergic projections to the 
medial prefrontal cortex showed decreased accuracy at the shortest signal 
duration when the distracter was presented. Infusions of 10OpM orexin A 
attenuated these impairments following the distracter in lesioned rats. The 
present results provide additional support that orexin A can enhance 
attentional performance under certain conditions and suggest that the basal 
forebrain is one structure that can mediate the effects of orexin A on attention.
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1Effects of Orexin A on Attention in Rats
Defining Attention
The construct of attention has been the subject of rigorous and multipronged 
investigation in psychological research over the past several decades. Although 
colloquial concepts of the meaning of attention abound, converging on a single 
definition has proved more difficult in empirical research. Broadly, "attention" 
refers to the ability to detect and organize salient stimuli while disregarding 
extraneous information (McGaughy & Sarter, 1995; Burk, 2004). A fundamental 
relation between attention and working memory has been described, such that the 
capacity and efficiency of working memory is significantly impacted by increases in 
attentional load (Awh & Jonides, 2001; Kane et al., 2001; Jha, 2002; Burk, 2004). 
Thus, attention may be conceptualized as a filter which regulates the selection of the 
most relevant information for a given situation to be evaluated within the limited 
capacity of working memory (Cowan, 1995; Burk, 2004). The development of 
adaptive attentional processing is complex, involving both automatic bottom-up 
processing of stimuli and more voluntary top-down control of the allocation of 
attentional resources (Knudsen, 2007). Bottom-up processing is the signal driven 
level of attention by which exposure to the stimulus enhances the ability to process 
the signals. In contrast, top-down modulation refers to the more cognitive aspects 
of attentional processing, reflected in the ability to respond appropriately to task 
rules and filter irrelevant stimuli based on knowledge or practice. Additionally, 
attention has been described as a set of several integrated processes, including
2selective focus on particular stimuli, attentional shift, and sustained attention over 
time (Bushnell & Strupp, 2009). These various aspects of attention may be 
individually taxed to study their contributions to normal attentional processing, 
which may help to elucidate the mechanisms by which a host of neurological 
conditions exert domain-specific effects on these processes (Gitelman, 2003).
Measuring Attention in Rats
Several behavioral measures have been developed with explicit attention 
demands that can be varied to study the components of attentional processing. The 
most extensively tested measure of attention in rats is the 5-choice serial reaction 
time test, in which rats are placed in a chamber and cued by a brief visual signal to 
enter one of five ports in order to receive a reward of food or water access (Carli et 
al., 1983; Bushnell & Strupp, 2009). This task can measure both sustained 
attention—by varying the duration of the visual signal and delay before the cue is 
presented—and selective attention, by introducing a distracting stimulus during task 
performance.
An alternative paradigm, the sustained attention task (SAT), has been 
developed based on a taxonomy of sustained attention to specifically tap the 
parameters of sustained attention in rats (Parasuraman et al., 1987; Bushnell, Kelly, 
& Crofton, 1994; McGaughy & Sarter, 1995). In this two-choice visual discrimination 
task, animals are required to discriminate between signal trials, in which lever 
presentation is preceded by the illumination of a panel light for a variable duration
3(500,100, or 25 ms in our lab) from nonsignal presentations in which animals must 
respond to the levers in the absence of the illumination of the panel light. Unlike 
vigilance tasks with simultaneous presentation of stimuli, the sustained attention 
task utilizes targets which are changes in a repetitive event from a single location, a 
manipulation which has been shown to impose greater memory load (Parasuraman, 
1987). Rats are trained to respond by pressing one lever in response to signal trials 
and the other lever in response to non-signal trials in order to receive a reward— 
typically delivery of a food pellet or controlled volume of water. Several dimensions 
of this task make it ideal for taxing sustained attention. The presentation of signal 
and nonsignal trials occurs in an unpredictable order and the time between trials can 
be varied. This combined with the ability to employ a dynamic range of stimuli 
rather than just one signal type increases vigilance demands in order to remain 
successful at the task (McGaughy & Sarter, 1995; Burk, 2004). Further, previous 
research has focused specifically on the impact of acute distraction on sustained 
attentional performance. Typically, this involves a manipulation in which the 
houselight in the testing chamber is flashed during some trials, which has been 
found to disrupt performance (Newman & McGaughy, 2008; Hirsh & Burk, 2013). 
Similar patterns of impairment have been observed during the distracter condition 
in a version of the sustained attention task adapted for use in measuring human 
attentional performance, suggesting that in both rats and humans, introducing a 
visual distracter requires the recruitment of additional attentional resources in order
4to filter out the irrelevant stimuli and continue to attend to the target (Bushnell et 
al., 2003; Demeter et al., 2008).
Neural Mechanisms Underlying Attention
Some of the earliest work investigating the neural mechanisms responsible 
for attentional processing used electrode recordings to measure activity in the 
superior colliculus during shifts in visual attention in macaque monkeys (Wurtz & 
Goldberg, 1972). Subsequent innovations in imaging technology provided the 
opportunity for further exploration of brain regions active during attention 
demanding tasks, finding evidence of a role for both the posterior parietal lobe and 
the anterior cingulate in the neuroanatomy of attention (Posner & Petersen, 1990, 
Casey et al., 1997). The neural mechanisms required for normal attention 
performance are widely distributed throughout the brain. The basal forebrain, 
which has diffuse projections of both cholinergic and noncholinergic neurons 
throughout the brain, has been the subject of considerable focus for its role in 
attentional processing.
Although GABAergic and glutamatergic neurons greatly outnumber 
cholinergic neurons in the basal forebrain, this region serves as the primary extrinsic 
source of acetylcholine (ACh) throughout the cortex (Mesulam et al., 1983; Robbins 
et al., 1989; Sarter et al., 2001). The basal forebrain cholinergic system (BFCS) is 
composed of six distinct regions, termed regions Chl-Ch6 (Mesulam et al., 1983).
The Ch4 region of the BFCS contains the nucleus basalis magnocellularis (nBM) and
5substantia innominata (SI) which are made up of a loosely clustered group of 
cholinergic neurons with diffuse projections to the prefrontal cortex (PFC) and other 
cortical regions (Mesulam et al., 1983). Using microdialysis, studies have confirmed 
that ACh levels in the rat cortex are elevated when animals are exposed to tasks 
which place explicit demands on attention compared with those that do not require 
sustained attention (Arnold et al., 2002; Sarter et al., 2001, 2005). In contrast, 
animals do not show an increase in cortical ACh release during performance on well- 
learned basic operant tasks, even when reinforcement rates were varied, 
presumably because the demands on attentional processing are lower in these tasks 
(Himmelhelber, Sarter, & Bruno, 1997).
Several studies have found these corticopetal cholinergic neurons in the 
basal forebrain to be necessary for normal attentional performance in rats. 
Excitotoxic lesions to the basal forebrain, for example, produce impairments in 
choice accuracy on the 5-choice serial reaction time test (Robbins et al., 1989). In a 
follow up study, Muir, Everitt, and Robbins (1995) found that treatments to restore 
cholinergic function with nicotine or the anticholinesterase physostigmine reversed 
these lesion-induced attentional deficits. Although this early work provided support 
for the growing body of literature implicating the basal forebrain in attention, the 
nonspecific nature of these lesions does not allow these attention mediating effects 
to be attributed exclusively to the loss of the cholinergic projections from the basal 
forebrain (Everitt & Robbins, 1997).
6The development of immunotoxins provided the opportunity to investigate 
the contributions of individual neuron systems to attentional processing more 
discretely. The cholinotoxin 192-lgG-saporin has been particularly useful in isolating 
the role of the basal forebrain cholinergic system in attention. The action of 192- 
lgG-saporin is facilitated by the antibody 192-lgG, which targets the p75 nerve 
growth factor receptors expressed exclusively by the cholinergic inputs to the cortex 
from the basal forebrain, allowing saporin to be internalized and transported to the 
cell nucleus where it blocks protein synthesis within the ribosomes resulting in cell 
death (Wiley, Oeltemann, & Lappi, 1991). Injections of this cholinotoxin into the 
prefrontal cortex result in the selective destruction of these p75 expressing 
cholinergic neurons within the basal forebrain while leaving other neuronal systems 
intact (Holley, Wiley, Lappi, & Sarter, 1994). Experiments which have employed 192- 
lgG-saporin have found that when it is infused into the basal forebrain in varying 
doses, it produces a corresponding array of damage in which the severity of the 
damage predicted the degree of performance deficit on a 5-choice serial reaction 
time task (McGaughy, Dailey, Morrison, Everitt, & Robbins, 2002). Intrabasalis 192- 
lgG-saporin has also been found to decrease performance on the sustained 
attention task, specifically by decreasing accuracy in signal detection (McGaughy et 
al., 1996). Moreover, Holley, Turchi, Apple, and Sarter (1995) reproduced these 
decrements in signal detection accuracy utilizing intrabasalis infusions of 
benzodiazepine receptor agonists, which reduce the activity of basal forebrain 
cholinergic neurons resulting in diminished cortical ACh release (Sarter et al., 1990).
7More intensive investigation of the cortical cholinergic projections from the 
basal forebrain has indicated that cortical acetylcholine release varies with 
attentional demand. Himmelheber and colleagues (2000) studied ACh efflux in the 
rat frontoparietal cortex using in vivo microdialysis as animals performed a sustained 
attention task. When a visual distracter was introduced during task performance, 
the rats showed an increase in cortical ACh efflux, presumably in response to the 
increased attentional demands created by the additional background noise. Rats 
trained on a version of the sustained attention task with minimal attentional 
demands do not show deficits in accuracy following loss of cortical cholinergic 
inputs. However, when multiple aspects of the task were manipulated to be more 
attention-demanding, rats with loss of basal forebrain corticopetal cholinergic 
neurons showed a significant decrease in signal detection (Burk, Lowder, and 
Altemose, 2008). Notably, only the manipulation of multiple task parameters to 
increase attentional demands—but not any one parameter alone—produced the 
observed disruptions in signal detection. Thus, no one parameter of the sustained 
attention task is independently crucial to observe deficits in attentional 
performance. Rather, multiple aspects of the task must be manipulated to be 
sufficiently attentionally taxing as to measure impairments in accuracy following 
lesions to the basal forebrain corticopetal cholinergic neurons. These findings 
provided support for previous reports that the efflux of cortical ACh facilitates the 
recruitment of additional attentional resources or increased attentional effort under 
more challenging conditions (Sarter, Gehring, & Kozak, 2006).
8Regulation of basal forebrain neurons
Given that the cortical cholinergic transmission facilitated by basal forebrain 
activation is critical for normal attentional performance, understanding the 
regulation of firing rates of basal forebrain corticopetal cholinergic neurons is 
important. Basal forebrain neurons are innervated by numerous neurotransmitter 
systems, projecting from several regions throughout the brain. The relative 
contributions of some of these inputs, which include GABAergic and glutamatergic 
systems, have been studied (Sarter et al., 1999). However, one more poorly 
characterized input is the hypothalamic orexinergic projections to the basal 
forebrain corticopetal cholinergic neurons. As the primary neurological structure 
responsible for coordinating the brain's ability to detect and respond to external 
cues, the hypothalamus may be of particular significance in mediating attentional 
performance. A group of hypothalamic neuropeptides, the orexins, (orexin A and 
orexin B, also known as hypocretin 1 and hypocretin 2) have become the focus of a 
growing body of research since their simultaneous discovery by two independent lab 
groups in 1998 (de Lecea et al., 1998; Sakurai et al., 1998). Although orexin neuron 
cell bodies are localized to the hypothalamus and contiguous perifornical area, they 
have projections throughout the brain, suggesting a role for orexin neuron activity in 
numerous physiological processes ranging from feeding to coordination of 
sleep/wake cycles (De Leccea et al., 1998; Sakurai et al., 1998). Orexinergic neurons 
have robust projections into the basal forebrain, forming synapses on the cholinergic 
as well as noncholinergic neurons in this region (Cullinan & Zaborszky, 1991). Using
immunohistochemistry, Fadel, Pasumarthi, and Reznikov (2005) provided evidence 
for the direct relationship between orexin fibers and cholinergic neurons, reporting 
that orexin-immunoreactive fibers were widely distributed throughout cholinergic 
regions of the basal forebrain and positioned closely to these cholinergic neurons. 
Two types of orexin receptors are expressed in the neurons of the basal forebrain, 
the orexin 1 receptor (OxlR) which binds with stronger affinity to orexin A, and the 
orexin 2 receptor (Ox2R) which binds both orexin A and orexin B with relatively 
equal affinity (Sakurai et al., 1998). It is hypothesized that these receptor subtypes 
play unique, complementary roles in modulating the activity of the basal forebrain 
(Fadel & Burk, 2010). Administration of orexin A to the basal forebrain in rats 
produces a substantial efflux of ACh in the cortex that is not observed when orexin is 
applied to the prefrontal cortex directly (Fadel et al., 2005). Moreover, intrabasalis 
infusion of an OxRl antagonist blocks stimulated ACh release (Frederick-Duus et al., 
2007). Although the lack of a commercially available antagonist for OxR2 places 
limitations on the ability to disambiguate which receptor subtypes are most 
influential in the excitatory effects of orexin in the basal forebrain, the available 
research clearly indicates a link between orexinergic neurons and the stimulated 
release of ACh to the cortex by the basal forebrain.
Orexins and attention
Initial physiological and behavioral studies related to orexin function focused 
largely on the role of orexin activity in regulating feeding behavior (Sakuri et al.,
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1998). Mouse models which have been genetically engineered to be deficient in 
leptin, a peptide hormone which acts within the hypothalamus to suppress appetite 
(ob/ob knockout mice), demonstrate diminished levels of the orexin precursor 
preprohypocretin mRNA (Yamamoto et al., 1999). Recent research has become 
increasingly focused on the influence of orexin on wakefulness, arousal, and 
attention. Human narcolepsy is marked by a profound loss of orexin peptides 
(Nishino et al., 2000; Peyron et al., 2000; Thannickal et al., 2000), and individuals 
with this condition have been found to demonstrate impairments in attentional 
processing even during periods of normal wakefulness (Nauman et al., 2006).
Further, mice which have been genetically modified to lack orexin producing 
neurons or orexin receptors exhibit symptoms analogous to those of human 
narcolepsy (Yamanaka & Tsunematsu, 2010). The recent development of techniques 
in optogenetics has allowed researchers to modulate the activity of orexinergic 
neurons in freely moving animals. In these experiments, orexin neurons which have 
been injected with light-sensitive proteins can be instantaneously activated or 
silenced using flashes of light, thus providing a model for isolating the effects of 
orexin neurons without allowing for other compensatory neuronal mechanisms to 
develop (Inutsuka & Yamanaka, 2013). The selective photostimulation of orexin 
neurons promotes the transition from non REM or REM sleep to wakefulness and 
increases the amount of wakefulness time (Adamantidis, et al., 2007; Carter et al., 
2009). Aged rats show a specific and sizable decrease in orexin expression and 
number of receptors, suggesting that a reduction in orexin levels may be also an
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important contributor to the attentional deficits resulting from age-related cognitive 
decline (Porkka-Heiskanen et al., 2004; Kessler, Stanley, Frederick-Duus, & Fadel, 
2011).
Several lines of research suggest that both orexin A and orexin B may be 
effective in enhancing attention. Transnasal administration of orexin A in rhesus 
monkeys reduced cognitive deficits related to sleep deprivation (Deadwyler et al., 
2007). In rats, administration of orexin B to the prefrontal cortex enhanced 
performance on a task that places high demands on attentional processing (Lambe 
et al., 2005). In contrast, both central and intrabasalis infusions of the orexin-1 
receptor antagonist SB-334867 have been found to disrupt different aspects of 
attentional performance (Boschen, Fadel, & Burk, 2009). Specifically, we have 
previously observed impaired detection of the longest signal duration following 
systemically administered SB-334867, whereas intrabasalis SB-334867 decreased 
overall accuracy on trials with longer signal durations (Boschen, Fadel, & Burk,
2009). Finally, orexin A administered centrally via the lateral ventricle (LV) leads to 
improvements in sustained attention task accuracy on trials that required animals to 
respond in the absence of a signal presentation, without producing enhancements 
on other measures of task accuracy (Hirsh & Burk, 2011).
Rationale for Present Experiments
Collectively, the available literature suggests that the integrity of both the 
BFCS and orexin producing neurons are essential to normal attentional processing.
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Given the accumulating neuroanatomical and behavioral data implicating these 
systems in attentional performance, the goal of the present studies was to localize 
the attention enhancing effects of orexin A and to clarify the roles of the basal 
forebrain corticopetal cholinergic neurons in this process. Thus, the primary 
objective of experiment 1 was to investigate whether orexin A infused directly into 
the basal forebrain would produce similar patterns of attentional enhancement to 
those observed previously in our lab following central administration of orexin A 
(Hirsch & Burk, 2011). In Experiment 2, we further investigated whether basal 
forebrain cholinergic neurons are necessary to mediate the relationship between 
orexin A and attention by measuring attentional performance following central 
infusions of orexin A in rats with and without lesions to medial prefrontal cortical 
cholinergic inputs from the basal forebrain.
Materials and Methods—Experiment 1 
Subjects
Male FBNF rats (N=6) approximately three months of age at the beginning of 
the experiment were used. The rats were individually housed in hanging wire cages 
in a vivarium which was temperature and humidity controlled and operated on a 
14:10 hour light/dark cycle. All rats were water restricted throughout the 
experiment, receiving water during behavioral testing and for 30 minutes after each 
testing session. Rats were trained five to seven days a week, and received at least 
one hour of water access on days when no behavioral testing occurred. Food was
13
provided ad libitum throughout the experiment. Animals were treated in 
accordance with the guidelines of the Animal Care and Use Committee at the 
College of William and Mary.
Apparatus
Animals were trained in the same box, located within a sound attenuating 
chamber, throughout the experiment. One side of each box contained two 
retractable levers, a water port positioned between the levers with a delivery dipper 
for providing reinforcement (0.01 ml tap water) for correct responses, and three 
panel lights. One panel light was located above each lever, and the third was 
located above the water port. The center light above the water port was used for 
the purposes of this study. A house light was positioned on the opposite side of 
each chamber for providing increased background noise during some trial blocks and 
dim illumination throughout testing sessions. Behavioral testing programs were 
operated by a personal computer using the Med-PC version IV software.
Behavioral training prior to orexin adm inistration
Training occurred between 9:00 a.m. and 12:00 p.m. daily. Training sessions 
lasted for 40 min or until rats had completed 162 trials. In the initial shaping 
procedure, rats were trained to press an extended lever using an FR-1 schedule of 
reinforcement. Once animals maintained 120 lever presses for a period of three 
days they were allowed to continue shaping. In the next shaping task, rats were
14
required to learn to discern signal (1-s illumination of the central panel light) from 
nonsignal trials in which the panel light remained unlit. Presentation of signals and 
nonsignals was pseudo-randomized across all 162 trials in a session. After a signal or 
no signal, the rats were cued to respond by extension of the levers into the 
chamber. Rules for training were counterbalanced, such that half of the rats were 
reinforced (3-s access to 0.01ml tap water) for pressing the left lever in response to 
a signal, which was recorded as a hit. A miss was recorded for right lever presses 
after a signal trial. For nonsignal trials, a press of the right lever was considered a 
correct rejection and water access was provided, while a press of the left lever in 
response to no signal presentation was recorded as a false alarm. The inter-trial 
interval (ITI) was 12-s during this stage of training. An incorrect response during this 
training phase would be followed by a correction trial which was the same trial type 
as that in which the error occurred. If the rat responded incorrectly for three 
consecutive trials, a forced trial occurred in which only the correct lever was 
extended into the chamber for 60-s or until the rat responded. The rules of the task 
were reversed for the other half of the rats such that a right lever press was 
considered a hit following a signal presentation whereas the left lever was 
considered a correct response to a nonsignal trial.
During the final phase of behavioral training animals were required to 
discriminate between shorter and variable signal durations (500ms, 100ms, 25ms) 
and nonsignals presented in random order across signal trials, and the ITI was varied 
(9±3 s). These changes to the signal duration and event rate were designed to
15
increase the attentional demand (Parasuraman et al., 1987; Koelega et al. 1990;
Burk, 2004). Each training session was comprised of 162 total trials (81 signal, 81 
non-signal). For the signal trials, each of the three signal durations was presented 
for 27 trials within a session. Trials were presented in blocks of 18 (9 non-signal, 9 
signal, with 3 of each signal duration) and trial types were selected randomly 
without replacement.
Surgical procedures
For rats receiving intrabasalis orexin administration, after stable performance 
levels were established (>70% hits on 500ms signal trials and 70% correct rejections 
on non-signal trials), animals received a surgical procedure in which guide cannulae 
were implanted bilaterally in the basal forebrain. On the night prior to surgery, rats 
were provided with 2.7 mg/ml acetaminophen via their drinking water. Rats were 
anesthetized via ip injections of 90.0 mg/kg ketamine combined with 9.0 mg/kg 
xylazine. Once animals were sedated, the surgical area was shaved with an electric 
razor and rats were positioned in a stereotaxic device with the incisor bar set at 3.3 
mm below the interaural line. All surgical procedures were conducted under aseptic 
conditions. Target coordinates for guide cannulae implantation were established 
using the stereotaxic atlas (-1.3mm anterior-posterior (AP) and + 2.7mm medial- 
lateral (ML) from bregma, -4.2mm from dura). An incision was made down the 
midline, exposing the skull, and holes were drilled over the target sites for cannulae 
implantation. An eight millimeter guide cannula was inserted in each side of the
basal forebrain, with internal cannula extending 3mm beyond the guide cannulae 
during infusion. Three stainless steel screws and dental cement were also used to 
secure the cannulae. Dummy cannulae were inserted to prevent blockage within 
the guide cannulae. Following surgery, animals were given a one week recovery 
period in which food and water were available ad libitum. Rats were then returned 
to water restriction and began to retrain on the behavioral task. All animals were 
housed in plastic tubs with wire tops following surgery for the duration of the 
experiment.
Drug Administration Procedures
Rats were considered candidates to begin infusion procedures when 
presurgical performance levels were matched. Prior to drug infusions, animals 
received at least two sham infusions, after which they were exposed to an 
augmented version of the behavioral task in which the houselight at the back of the 
chamber was flashed during the second block of trials (1.0 s on /  1.0s off) to 
increase attentional demands. These sham sessions were designed to allow rats to 
become accustomed to the infusion process before drug administration. Each 
animal received four orexin doses: vehicle solution, O.lpM, l.OpM, lOpM, infused in 
random order bilaterally into the basal forebrain. These doses were chosen because 
they fall within the range known to be sufficient to produce stimulation of cortical 
acetylcholine release when infused into the brain, and the ten-fold increase in dose 
was expected to generate measurable differences in the magnitude of effects (Fadel, 
Pasumarthi, & Reznikov, 2005). Infusions were made through the insertion of an
17
internal cannula attached to a Hamilton syringe by polyethylene tubing. A total 
volume of 0.5 pi solution was infused into each cannula at a rate of 1.0 pl/min (Hirsh 
& Burk, 2011). The internal cannula was left in place for one minute following the 
completion of each infusion to allow for drug diffusion. Animals were then 
immediately loaded into the chambers to begin behavioral testing. At least one day 
of training was allowed between each testing session to re-establish baseline 
performance. Figure 1 illustrates approximate sites of basal forebrain infusions.
Histological procedures
After being deeply anesthetized via an ip injection of 90 mg/kg ketamine and 
9.0 mg/kg xylazine, rats were transcardially perfused with 10% sucrose followed by 
10% formalin at a pressure of 300mmHg using a Perfusion One apparatus. The 
brains were then harvested and placed in formalin for 48 hours before being put 
into a 30% sucrose solution in phosphate buffered saline for at least three days.
The tissue was then sectioned in 50pl slices using a freezing microtome. Sections 
nearest the cannula sites were stained using cresyl violet and viewed under a 
microscope to assess cannula placement.
Materials and Methods—Experiment 2
Subjects
Male FBNF rats approximately three months in age at the beginning of the 
study were used. The rats were housed under similar conditions as in experiment 1. 
Surgical Procedures
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Presurgical training, determination of surgical candidacy and surgical 
preparations were identical to those in experiment 1. Target coordinates for 
implantation of a single guide cannula into the lateral ventricle were established 
using the stereotaxic atlas (-0.8mm AP, 1.6mm ML, -2.5mm DV from bregma). The 
hemisphere in which the cannula was implanted was counterbalanced, such that 
half of the animals received a cannula in the left hemisphere and half received a 
cannula in the right hemisphere. An eight millimeter guide cannula was inserted 
into the lateral ventricle, with internal cannula extending 1mm beyond the guide 
cannula during infusion (Figure 2). Three stainless steel screws and dental cement 
were again used to secure the cannula. During the same surgery, rats received 
infusions of either the immunotoxin 192-lgG-saporin (0.2 |ig/|il; 0.5pl per site) or 
saline into the medial prefrontal cortex (3.7mm AP, 0.7mm ML, -3.5 mm from dura; 
2.6 mm AP, 0.7mm ML, -3.5 mm from dura). Postsurgically, animals were again 
given a one week recovery period during which food and water were available ad 
libitum, and then returned to water restriction and retrained on the behavioral task. 
Postsurgical Behavioral Testing Procedures
Following the recovery period, all animals completed 15 sessions on the 
same version of the sustained attention task on which they were trained prior to 
surgery in order to assess any effects of lesion on performance before exposure to 
drug infusions. Performance was averaged across blocks of 3 sessions, thus a total of 
five 3-session blocks were used for subsequent analysis.
Drug Administration Procedures
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Drug infusion procedures were performed similarly to those in experiment 1, 
except that the drug doses were increased (0, lOpM, lOOpM, lOOOpM) to account 
for infusion into the LV instead of directly into the basal forebrain. On sham and 
drug infusion sessions, rats were tested in a version of the sustained attention task 
with the flashing houselight distracter presented during the second block of trials 
(trials 55-108) within the session.
Histological Procedures
After completion of all behavioral testing, rats were deeply anesthetized and 
transcardially perfused using 10% sucrose followed by 4% paraformaldehyde. The 
harvested brains were placed in the same paraformaldehyde fixative for at least 24 
hours before being placed in a 30% sucrose phosphate buffer for cryoprotection and 
refrigerated. Sections (50pM) from the prefrontal cortex region as well as those 
near the cannula site were preserved in an antifreeze solution until they underwent 
acetycholinesterase (AChE) fiber staining. AChE histochemistry was performed on 
frozen tissue using previously described procedures (Tago et al.,1986; McGaughy et 
al., 1996). Brain tissue sections were first rinsed in a 0.1 M phosphate buffer 
solution and then incubated in hydrogen peroxide for 20 minutes. Sections were 
then rinsed in maleate buffer before being immersed in a solution composed of 0.5 
ml of 0.1 M sodium citrate, 1.0 ml of 5 mM potassium ferricyanide, 1.0 ml of 30 mM 
cupric sulfate and 10.0 mg of acetylthiocholine into 197.5 ml of 0.1 M maleate 
buffer for 30 minutes. After rinsing in 50.0 mM Tris buffer (pH 7.6), sections were 
incubated for 10 minutes in the solution prepared using the provided instructions in
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a diaminobenzidine (DAB) kit. At the end of the incubation period, drops of 0.1% 
hydrogen peroxide were added to the sections until tissue staining was complete. 
Brain tissue sections were mounted on gelatin coated slides and allowed to dry. 
Slides were then dehydrated and coverslipped.
Behavioral Measures and Statistical Analyses
Performance accuracy in the sustained attention task is determined through 
the assessment of hits, misses, correct rejections, and false alarms. The number of 
hits (H), misses (M), correct rejections (CR), false alarms (FA) and omissions were 
recorded for each animal during each testing session. The relative number of hits 
and correct rejections per block and for the overall testing session were calculated 
as [H/(H+M)j and [CR/(CR+FA)j respectively. The range of scores for relative hits is 
from 0 (the animal pressed the correct rejection/miss lever every time a signal was 
presented) to 1 (the animal pressed hit/false alarm lever following each signal 
presentation). The range of scores is the same for relative correct rejections, with 
the opposite lever being pressed in response to no signal presentation for values of 
0 and 1. For the distracter task, all measures were calculated for the entire session, 
as well as for each of three 54-trial blocks within a session. To determine the effect 
of the distracter for each rat, a distracter score was calculated, reflecting the 
difference between all behavioral measures between block 1 (standard task with no 
distracter) and block 2 (distracter presentation). Thus, positive values indicate 
greater accuracy during block 1, whereas negative values indicate greater accuracy
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during block 2 and a greater difference in accuracy between block 1 and block 2 is 
indicated as values become increasingly positive or negative.
The overall SAT accuracy, which takes into account performance on both 
signal and non-signal trials, was also calculated for each animal using the formula 
SAT=((H-FA)/(2x(H+FA)-(H+FA)2) (McGaughy et al., 1996; Boschen et al., 2009). The 
range of scores for the SAT measure is from -1 to 1, where a score of 1 indicates 
100% correct responses on signal and non-signal trials and a value of 0 indicates an 
inability to discriminate between signal and non-signal trials. Analyses of omissions 
were conducted separately from those of hits and correct rejections. Data were 
analyzed with SPSS 19.0 for Windows (SPSS, Chicago, IL, USA). A level of a=0.05 was 
used as the criterion for statistical significance.
Histological Analyses
AChE-positive fibers were quantified in the prelimbic/infralimbic (PI/IL) 
region of the cortex as well as the primary motor(Ml) regions in sections from both 
lesioned and sham lesioned animals. AChE-positive fiber density was quantified 
using a modified counting grid method described by Burk, Lowder, and Altemose 
(2008). Using an Olympus BX-51 light microscope with an objective lens 
magnification of 40X, three lines that bisected each other at the midpoint were 
placed over the image using the Grid Mask function in ImagePro Discovery. Grid 
parameters were set to a radius of 400 with segments of 10. Image size was set to 
50%. Each time a fiber crossed the lines was counted and a percent loss was
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determined. Figure 3 includes images representative of sections from lesion and 
sham-lesion groups.
Results -  Experiment 1 
Six rats maintained stable task performance throughout postsurgical testing 
and had cannula placement confirmed by identifying tissue loss and gliosis indicating 
the location of the guide cannulae. Intrabasalis orexin A did not affect performance 
on the standard task without the distracter (block 1). A dose (0, 0.1,1, and lOpM 
orexin A) x signal duration (500,100, and 25ms) ANOVA was conducted for the SAT 
measure which yielded no significant effect of orexin A dose. A similar set of 
analyses was conducted for the relative hits, as well as nonsignal trials and omission 
rates. These analyses also yielded no significant effect of drug dose on any of these 
measures during the first block of trials (Figure 4).
Distracter scores (bl-b2) were calculated for each rat for both relative hits 
and the SAT measure to assess the effects of the distracter. This measure indicates 
the impairment in performance in response to the visual distracter presented during 
block 2, with lower scores representing less of a decrease in attentional 
performance between the first and second block of trials. A dose (0, 0.1,1.0, lOpM 
orexin A) x signal duration (3 levels) yielded a significant dose x signal duration 
interaction (F(6,30) = 2.866, p = 0.025) for the difference score SAT measure. Follow 
up analyses revealed a significant main effect of dose at the 500ms level (F(3,15)= 
6.697, p = .004), but not at the 100ms or 25ms signal durations (Figure 5). For hits,
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this effect was mirrored by analyses of accuracy on signal trials. For hits, there was a 
significant dose x signal duration interaction for the distracter score(F(6,30) = 2.689, 
p=0.033). Follow up analyses again revealed a main effect of dose at the 500ms 
signal duration (F(3,15) = 6.697, p = .004), but not at the 100ms or 25ms levels 
(figure 6). Further analyses via paired sample t-tests compared each orexin A dose 
with vehicle administration. Performance following 10 pM orexin A was significantly 
different compared to vehicle at the longest (500 ms) signal duration (t(5)=2.766, 
p=0.040). Thus, at the longest (500 ms) signal duration, the lOpM orexin A dose 
decreased the distracter score for relative hits (bl-b2) compared with vehicle 
administration, suggesting that orexin A infusions decreased distractibility at this 
dose. There were no significant effects of orexin A dose on correct rejections or 
omissions for the distracter score.
Finally, dose x signal duration ANOVAs were conducted for the SAT measure, 
relative hits, correct rejections, and omissions on the standard task following the 
distracter (block 3). These analyses also yielded no significant effect of orexin A 
dose during the third block of trials (Figures 7, 8).
Results -  Experiment 2
Histological Analyses
One lesioned animal was dropped from analysis due to difficulties with 
histological assessment. All remaining lesioned animals and a subset of the sham- 
lesioned animals were included in subsequent histological analysis. On average,
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lesioned animals showed a 60.8% loss of AChE-positive fibers compared to sham 
lesioned animals. A t-test comparing the mean AChE fiber counts from the medial 
PFC and M l regions was conducted, and results from this analysis confirmed that 
lesioned animals showed significantly fewer AChE fibers in the prelimbic portion of 
the medial prefrontal cortex than sham-lesioned animals (t(14)=10.769, p < .001; 
mean ± SEMs for AChE-positive fiber counts: sham-lesioned animals, 61.18 ±3.61; 
lesioned animals, 23.98 ±1.62). These analyses yielded no significant differences in 
AChE-positive fiber counts in the primary motor cortex (t(14)=.268, p=.792; mean ± 
SEMs for AChE-positive fiber counts: sham-lesioned animals, 61.59 ± 2.79; lesioned 
animals, 60.68 ± 2.07).
Performance prior to orexin A infusions
The data reported here are from the 19 rats (10 lesion, 9 sham-lesion) which 
maintained stable performance levels across infusion sessions. No significant 
differences were observed in performance between lesion and sham-lesion groups 
on the three days prior to surgery. A repeated-measures block (5 levels) x signal 
duration (3 levels) x lesion (2 conditions) ANOVA on the relative hits, correct 
rejections, and omissions during the first 15 days of training on the standard task 
following surgery found a main effect of signal duration on relative hits (F(2,34)= 
288.35, p < 0.001). Rats exhibited signal duration dependent accuracy, with higher 
hit rates following longer signal durations. These analyses yielded no significant 
effect of lesion on any measure. To further confirm there were no differences 
between sham-lesioned and lesioned rats prior to drug exposure, the first and last
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three sessions of the 15 day training period were assessed, and revealed no 
significant group differences in accuracy on relative hits, correct rejections, or 
omissions.
Effects of Orexin A Infusions on attention task performance
Following drug infusion, omissions increased substantially at the highest 
orexin dose (1000 pM), rendering the measures of accuracy difficult to interpret. 
Therefore, task performance was subsequently analyzed following 0 (vehicle), lOpM 
and lOOpM orexin A infusions. The overall SAT measure, taking into account 
performance on both signal and non-signal trials was calculated for all animals and 
these values were analyzed using lesion (2 conditions) x dose (0,10, lOOpM orexin 
A) x signal duration (3 levels) ANOVA for the first block of trials. This analysis yielded 
a significant lesion x dose x block interaction (F(4.64) = 2.983, p = 0.025) for the SAT 
measure during block 1. The basis for this interaction appeared to be differences at 
the 25ms signal duration, however follow up analyses did not reveal any statistical 
differences between lesioned and sham-lesioned groups at this level. A similar 
analysis was conducted for relative hits, correct rejections, and omissions during 
block 1 of trials and yielded no significant effects (figures 9,10). The distracter score 
(bl-b2) was calculated for each behavioral measure similarly to experiment 1. For 
SAT, a lesion (2 conditions) x dose (0,10, lOOpM orexin A) x signal duration (3 levels) 
ANOVA yielded a lesion x dose x signal duration interaction which was approaching 
significance (F(4,64) = 2.313, p = 0.067). For relative hits, these analyses revealed a 
significant lesion x dose x signal duration interaction (F(4,68) = 2.656, p = 0.040) for
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the distracter score. This interaction was further assessed by conducting dose X 
lesion ANOVAs at each signal duration. For the distracter score for relative hits, 
there was a significant dose x lesion interaction (F(2,34) = 4.965, p=0.013) at the 
25ms signal duration, but not on 500-ms or 100-ms signal trials (figure 11). This 
dose X lesion interaction was further assessed with separate one-way ANOVAs for 
dose for sham-lesioned and lesioned animals. No significant effects of dose were 
observed for the sham-lesioned animals (F(2,16) = .676, p = .523). There was, 
however, a significant main effect of dose on accuracy at the 25ms signal duration 
for the lesioned group (F(2,18) = 6.922, p = 0.006). To clarify the nature of this 
effect, follow up analysis via paired sample t-tests comparing each orexin A dose 
with vehicle administration for the lesioned animals were conducted. These analyses 
yielded a significant difference in the bl-b2 scores following vehicle versus 100 pM 
orexin A (t(9) = 2.973, p = 0.016). Thus, at the 25 ms signal duration, the lOOpM 
orexin A dose decreased the distracter score for relative hits compared with vehicle 
administration, indicating that the lateral ventricle infusions of lOOpM orexin A may 
reduce distractibility at the 25ms level. There were no significant effects of orexin A 
dose on correct rejections or omissions for the distracter score.
Finally, dose x signal duration ANOVAs were conducted for the SAT measure, 
relative hits, and correct rejections, and omissions on the standard task following 
the distracter (block 3). These analyses also yielded no significant effect of orexin A 
dose during the third block of trials (figures 12,13).
27
Discussion 
Effects of intrabasalis orexin A infusions
The present experiments tested whether the attentional enhancements
produced by orexin A are mediated by the basal forebrain. Effects of the distracter 
were determined by distracter scores that compared differences in accuracy on 
block 1 to block 2 of sessions. Infusions of orexin A directly into the basal forebrain 
diminished the impairment in performance in response to the greater attentional 
demands presented during the distracter task, particularly at the highest dose and at 
the 500ms signal duration. Sarter et al. (2005) identified two distinct mechanisms 
which are involved in the activation of the cortical cholinergic system during 
attention demanding tasks. Signal driven processing reflects the bottom-up level of 
processing by which the exposure to the stimulus enhances the ability to process the 
signals, while cognitive modulation of signal detection reflects the ability to respond 
appropriately based on task rules. Boschen et al. (2009) found that intrabasalis 
administration of the selective orexin-1 receptor antagonist SB-334867 resulted in a 
pattern of impairments only at the longest signal duration. Boschen et al. (2009) 
interpreted this finding to reflect an impairment in activating the appropriate rules 
after signal presentation. Similarly, intrabasalis orexin A may have enhanced the 
ability to generate the correct signal guided response without significantly impacting 
signal driven processing. Enhancements were observed only on distracter scores in 
the present experiment, suggesting that these beneficial effects occur primarily 
under conditions that increase demands on attention.
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Effects of LV orexin A infusions in sham-iesioned animals
Overall, no significant effects of LV orexin A infusions were observed in the 
sham-lesioned animals. Previous findings in our lab suggest that orexin A infused 
into the lateral ventricle could be expected to produce an increase in accuracy on 
correct rejections in intact animals (Hirsh & Burk, 2011). In the current study, rats 
reached higher levels of accuracy on nonsignal trials during the training period 
before beginning infusions (correct rejections following vehicle administration,
74.3% in the previous study vs. 82% in the present experiment). Thus, one possible 
explanation is that the higher levels of training and performance accuracy at 
baseline among animals in the present experiment may have limited our ability to 
observe noticeable changes in performance above and beyond their baseline 
performance. Alternatively, it may be that, in the previous experiment, the rats 
were still learning the task and that orexin A has more beneficial effects on learning. 
Previous research has demonstrated that LV infusions of orexin A can enhance 
learning in a passive avoidance task (Telegdy & Adamik, 2002), whereas 
administration of an orexin A antagonist to the ventral tegmental area (VTA) impairs 
learning of reward-associated cues (Harris et al., 2007). Additionally, future research 
could investigate whether orexin A enhances learning through overlapping neural 
circuits compared with any effects on attention.
Effects of loss of mPFC cholinergic inputs
29
Lesions of the mPFC cholinergic inputs did not significantly affect standard 
task performance. Under the distracter condition, sham-lesioned rats demonstrated 
an increase in accuracy at the 25ms signal duration from block 1 to block 2, 
presumably because the houselight flashes during the second block of trials instead 
of remaining consistently illuminated resulting in some of the 25ms signal 
presentations occurring when the chamber is dark. Thus, during the distracter task, 
some of the brief 25ms signals may be easier to discern than during the standard 
task. Lesioned animals demonstrated a decrease in accuracy on 25-ms signal trials 
when the distracter was presented, suggesting that loss of mPFC cholinergic inputs 
may impair the ability to fully take advantage of this benefit of the distracter at the 
shortest signal duration. However, following administration of orexin A, lesioned 
animals were able to recover a pattern of accuracy similar to that of animals with 
intact mPFC cholinergic systems. For lesioned rats, orexin A did not affect 
performance at the 500ms or 100ms signal durations. Taken together, these results 
suggest that intraventricular orexin A may enhance attentional performance at the 
shortest signal durations by altering the rats' criterion for identifying events as 
signals, which would be expected to be most salient at the 25ms level when it is the 
most difficult to discern signal from nonsignal presentation.
Limitations and Future Directions
The present study utilized a well-defined test of attention to measure 
enhancements in attentional processing, however a number of important limitations
30
should be considered. Of course, infusion studies convey an inherent risk of 
affecting circuitry outside of the intended target. The mRNA for both Oxl and 0x2 
receptors is widely distributed throughout the brain, and orexins have been shown 
to produce excitatory actions on many neuronal systems in addition to the BFCS, 
including noradrenergic locus coeruleus neurons, histaminergic neurons, and 
cholinergic mesopontine neurons (Prashant et al., 1998; Bayer et al., 2004). Infusions 
into the lateral ventricle allow the spread of orexin A to diffuse brain regions, thus, 
the effects of the drug on attentional performance cannot be attributed exclusively 
to its interaction with the basal forebrain. Although intrabasalis infusions of orexin A 
allow for the more specific targeting of the region of interest, orexin receptors are 
found on both cholinergic and non-cholinergic neurons within the basal forebrain. 
Future studies should be directed at clarifying the neuroanatomical circuitry 
underlying the effects of orexins in the basal forebrain by examining orexin A 
induced changes in attentional performance in animals with lesions specific to the 
noncholinergic basal forebrain neurons.
Histological analyses of AChE-positive fibers indicated that there was a 
significant, but not total, loss of cholinergic projections to the prelimbic region of the 
cortex. Thus, it is likely that some cholinergic transmission is still occurring in this 
region via these intact neurons. It is unknown whether the attention enhancing 
effects of orexin A in experiment 2 can be attributed to greater activation of the 
remaining cholinergic neurons or the interactions of orexin with other neuronal 
systems. Moreover, the potential compensatory processes to provide some
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functional recovery following loss of cholinergic projections were not characterized 
in the present experiment. Infusions of orexin A have been shown to increase ACh 
efflux within the PFC (Fadel et al., 2005). A microdialysis study would be useful in 
confirming the effects of the lesions produced by the selective cholinotoxin 192-lgG- 
saporin on ACh availability.
Collectively, the results of the present study contribute to the existing body 
of literature indicating the effectiveness of the distracter condition on the SAT task 
in impairing attentional performance. Further, although these results differ 
somewhat from previous findings in our lab in which the enhancements were 
observed exclusively on nonsignal trials, the present data are consistent with the 
idea that orexin A administration improves performance on a task specifically 
designed to tax sustained attention. Our results indicated that some of the 
attention-enhancing effects of orexin A may be mediated by the basal forebrain 
cholinergic system, however, it is likely that other noncholinergic neuronal systems 
also interact with orexin to produce its effects. Future studies should be aimed at 
gaining a better understanding the clinical utility of the effects of orexin A. Finally, it 
is important to note that although promising, the size of the attention-enhancing 
effects of orexin A is small. While our results contribute to the existing literature 
suggesting that orexins are involved in the modulation of normative attentional 
performance, further research is needed to determine the clinical utility of orexin A 
and investigate more viable mechanisms for administration in human populations.
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MCRO
Figure 1. Cannula placements within the basal forebrain at -1.3 mm to 
bregma. Circles indicate the location of the infusion cannula, which 
extended 3 mm beyond the guide cannula.
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Figure 2. Cannula placement for lateral ventricle infusions (0.8mm AP, 
1.6mm ML, -2.5mm DV from bregma), with internal cannula 






Figure 3. The figure depicts acetylcholinesterase (AChE)-positive fiber staining in sham- 
lesioned and lesioned tissue. The column on the left contains images from a sham-lesioned 
animal, and the right column (b., d.) are from a lesioned animal. Images in the top row (a., b.) 
are from sections in the primary motor cortex (M l), whereas images in the bottom row (c., d.) 
are from sections in the medial prefrontal cortex (mPFC). Lesioned animals exhibited a 













Veh. O.lpM l.OpM lOpM
Figure 4. Attention task performance following intrabasalis administration 
of orexin A (0.0, 0 .1 ,1 .0 ,1 0 .0  pM, n=6). There were no effects of drug 
dose on relative hits during block 1 of the attention task. Error bars 




























Figure 5. SAT measure, which takes into account accuracy on trials both with and 
without signal presentation, for difference scores (Block 1-Block 2). Intrabasalis 
orexin A at the highest (lO pM ) dose significantly reduced the measure of overall 
distracter-induced impairement at the longest (500ms) signal duration. Error bars 
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Figure 6. Attention task performance following intrabasalis administration of 
orexin A (0.0, 0 .1 ,1 .0 ,1 0 .0  pM, n=6). Compared to vehicle, intrabasalis orexin 
A (10.0 pM) significantly reduced the decrease in accuracy on relative hits from  
block 1 to block 2 in which the distracter was presented at the longer signal 















Veh. O.lpM l.OpM lOpM
Dose
Figure 7. Attention task performance following intrabasalis administration of 
orexin A (0.0, 0 .1 ,1 .0 ,1 0 .0  pM, n=6). There were no effects of drug dose on 
relative hits during block 3 of the attention task. Error bars represent standard 


























Figure 8. Attention task performance following intrabasalis administration of 
orexin A (0.0, 0 .1 ,1 .0 ,1 0 .0  pM, n=6). Correct rejections were unaffected by 

























Figure 9. Attention task performance following lateral ventricle administration 
of orexin A (0 .0 ,10 .0 , lOOpM). There were no significant effects of drug dose 




















Figure 10. There were no significant effects of drug dose on relative hits at 
any signal duration during block 1 for animals with 192-lgG-saporin induced 































Figure 11. Animals with 192-lgG-saporin induced lesions exhibited a shift in 
the pattern of accuracy changes from block 1 to block 2 for relative hits 
following infusions of the highest orexin A dose. The performance of sham- 
lesioned animals was not affected by orexin A at any dose. Error bars 
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Figure 12. There were no significant effects of drug dose on the 
accuracy of sham-lesioned animals during standard task performance 
on the third block of trials following the distracter task. Error bars 






















Figure 13. There were no significant effects of drug dose on the accuracy of 
sham-lesioned animals during standard task performance on the third block 
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